scholarly journals The prevalence and clinical implications of pancreatic fat accumulation identified during a medical check-up

Medicine ◽  
2021 ◽  
Vol 100 (41) ◽  
pp. e27487
Author(s):  
Kosuke Okada ◽  
Takahisa Watahiki ◽  
Kaoru Horie ◽  
Takako Takayama ◽  
Yuka Aida ◽  
...  
2020 ◽  
Vol 11 (5) ◽  
pp. 1188-1196
Author(s):  
Ayako Fukase ◽  
Tomoyasu Fukui ◽  
Hiroto Sasamori ◽  
Munenori Hiromura ◽  
Michishige Terasaki ◽  
...  

2017 ◽  
Vol 53 (7) ◽  
pp. 873-882 ◽  
Author(s):  
Hajime Yamazaki ◽  
Shinichi Tauchi ◽  
Miho Kimachi ◽  
Mitsuru Dohke ◽  
Nagisa Hanawa ◽  
...  

Diabetes Care ◽  
2011 ◽  
Vol 34 (2) ◽  
pp. 485-490 ◽  
Author(s):  
K.-A. Le ◽  
E. E. Ventura ◽  
J. Q. Fisher ◽  
J. N. Davis ◽  
M. J. Weigensberg ◽  
...  

2021 ◽  
Vol 10 (6) ◽  
pp. 1326
Author(s):  
Junji Kozawa ◽  
Iichiro Shimomura

Ectopic fat is found in liver, muscle, and kidney and is known to accumulate as visceral fat. In recent years, ectopic fat has also been observed in the pancreas, and it has been said that pancreatic fat accumulation is related to the pathophysiology of diabetes and the onset of diabetes, but the relationship has not yet been determined. In the heart, epicardium fat is another ectopic fat, which is associated with the development of coronary artery disease. Ectopic fat is also observed in the myocardium, and diabetic patients have more fat accumulation in this tissue than nondiabetic patients. Myocardium fat is reported to be related to diastolic cardiac dysfunction, which is one of the characteristics of the complications observed in diabetic patients. We recently reported that ectopic fat accumulation was observed in coronary arteries of a type 2 diabetic patient with intractable coronary artery disease, and coronary artery is attracting attention as a new tissue of ectopic fat accumulation. Here, we summarize the latest findings focusing on the relationship between ectopic fat accumulation in these organs and diabetic pathophysiology and complications, then describe the possibility of future treatments targeting these ectopic fat accumulations.


Radiology ◽  
2014 ◽  
Vol 271 (1) ◽  
pp. 104-112 ◽  
Author(s):  
So Yeon Kim ◽  
Haeryoung Kim ◽  
Jai Young Cho ◽  
Soo Lim ◽  
Kyusun Cha ◽  
...  

Author(s):  
Robert Wagner ◽  
Sabine S. Eckstein ◽  
Hajime Yamazaki ◽  
Felicia Gerst ◽  
Jürgen Machann ◽  
...  

Angiology ◽  
2021 ◽  
pp. 000331972110383
Author(s):  
Sinan Sahin ◽  
Aysegul Karadeniz

We investigated the relationship between pancreatic fat accumulation and markers of atherosclerosis among patients with nonalcoholic fatty liver disease (NAFLD). Patients with NAFLD have been reported to be at an increased risk of vascular events. We grouped 183 patients in whom we detected and graded hepatosteatosis (HS) on transabdominal ultrasonography into 2 groups based on the presence/absence of pancreatic fat. There were 85 participants (50 female; mean age: 53.6 ± 9.7 years) who were nonalcoholic fatty pancreas disease (NAFPD) positive and 98 participants (56 female; mean age: 51.4 ± 9.3 years) who were NAFPD negative. Carotid intima media thickness (cIMT) was significantly greater in the group where HS was accompanied by NAFPD (0.51 [0.40–0.62] vs 0.45 [0.35–0.55] mm; P < .001). Multivariable analyses showed that the independent predictors of increased cIMT were age (odds ratio [OR]: 1.108; 95% CI: 1.059–1.158, P = .001), hypertension (OR: 2.244; 95% CI: 1.099–4.579, P = .026), and the presence of NAFPD (OR: 3.078; CI 95% CI: 1.531–6.190, P = .0002). In the present study we demonstrated that, in patients with NAFLD, pancreatic fat accumulation was significantly associated with cIMT, a marker of early atherosclerosis. NAFPD may increase the risk of vascular events associated with NAFLD.


Sign in / Sign up

Export Citation Format

Share Document